Unfortunately, EMab-17 was not suitable for Western blot and immunohistochemical analyses (data not shown); therefore, EMab-51 or EMab-134 should be used for diagnosing EGFR expression in cancer patients. The gene discussed is EGFR; the disease is cancer.